Header cover image

French (CAC) Pharma Industry Analysis

UpdatedDec 15, 2025
DataAggregated Company Financials
Companies6
  • 7D-0.5%
  • 3M5.5%
  • 1Y-4.5%
  • YTD-9.7%

Over the last 7 days, the Pharma industry has remained flat, although notably MedinCell gained 3.3%. Unfortunately though, the industry is down 4.5% over the past 12 months. Earnings are forecast to grow by 12% annually.

Industry Valuation and Performance

Has the French Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 15 Dec 2025€115.9b€53.0b€7.0b21.3x16.6x2.2x
Wed, 12 Nov 2025€123.7b€53.0b€7.0b22.3x17.8x2.3x
Fri, 10 Oct 2025€117.3b€52.9b€6.9b20x17x2.2x
Sun, 07 Sep 2025€111.1b€52.8b€6.9b18.7x16.1x2.1x
Tue, 05 Aug 2025€113.1b€52.8b€6.9b19.4x16.3x2.1x
Thu, 03 Jul 2025€114.6b€52.1b€6.7b18.2x17.2x2.2x
Sat, 31 May 2025€119.6b€52.1b€6.7b19.2x18x2.3x
Mon, 28 Apr 2025€125.2b€52.1b€6.7b18.2x18.8x2.4x
Wed, 26 Mar 2025€140.1b€51.2b€5.9b17.9x23.6x2.7x
Fri, 21 Feb 2025€142.9b€51.2b€5.8b18.3x24.7x2.8x
Sun, 19 Jan 2025€136.8b€55.2b€5.1b18.3x26.9x2.5x
Tue, 17 Dec 2024€124.6b€55.2b€5.1b19.6x24.4x2.3x
Thu, 14 Nov 2024€131.6b€55.2b€5.1b21.2x25.8x2.4x
Sat, 12 Oct 2024€140.1b€53.8b€4.8b22.6x29.2x2.6x
Mon, 09 Sep 2024€144.9b€53.8b€4.8b19.5x30.2x2.7x
Wed, 07 Aug 2024€130.4b€53.8b€4.8b20.8x27.2x2.4x
Fri, 05 Jul 2024€128.1b€52.9b€5.2b20.1x24.8x2.4x
Sun, 02 Jun 2024€127.3b€52.9b€5.2b21.7x24.6x2.4x
Tue, 30 Apr 2024€128.9b€52.9b€5.2b21x24.9x2.4x
Thu, 28 Mar 2024€128.4b€52.7b€6.0b21.2x21.2x2.4x
Sat, 24 Feb 2024€126.5b€53.0b€6.3b20.5x20.2x2.4x
Mon, 22 Jan 2024€132.0b€52.2b€9.7b19.6x13.6x2.5x
Wed, 20 Dec 2023€125.6b€52.2b€9.7b18.3x12.9x2.4x
Fri, 17 Nov 2023€118.0b€52.2b€9.7b16.8x12.1x2.3x
Sun, 15 Oct 2023€144.0b€52.6b€9.3b17.4x15.5x2.7x
Tue, 12 Sep 2023€143.1b€52.6b€9.3b20.4x15.5x2.7x
Thu, 10 Aug 2023€136.5b€52.6b€9.3b21.4x14.7x2.6x
Sat, 08 Jul 2023€131.3b€52.6b€9.1b17.3x14.4x2.5x
Mon, 05 Jun 2023€133.0b€52.6b€9.1b15.4x14.5x2.5x
Wed, 03 May 2023€135.7b€52.6b€9.1b15.5x14.8x2.6x
Fri, 31 Mar 2023€137.9b€51.8b€9.2b15.5x15.1x2.7x
Sun, 26 Feb 2023€126.8b€51.7b€9.2b17.4x13.8x2.5x
Tue, 24 Jan 2023€125.8b€50.7b€7.4b18.5x17.1x2.5x
Thu, 22 Dec 2022€127.4b€50.7b€7.4b17x17.3x2.5x
Price to Earnings Ratio

17.3x


Total Market Cap: €127.4bTotal Earnings: €7.4bTotal Revenue: €50.7bTotal Market Cap vs Earnings and Revenue0%0%0%
French Pharma Industry Price to Earnings3Y Average 19.4x202320242025
Current Industry PE
  • Investors are pessimistic on the French Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 16.6x which is lower than its 3-year average PE of 19.4x.
  • The 3-year average PS ratio of 2.5x is higher than the industry's current PS ratio of 2.2x.
Past Earnings Growth
  • Both revenue and earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • This means that sales and the cost of doing business have remained relatively consistent over this period and subsequently, so have profits.

Industry Trends

Which industries have driven the changes within the French Healthcare industry?

FR Market-0.23%
Healthcare-3.50%
Pharma-0.47%
Pharma-0.47%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
VETO Vetoquinol€77.700.6%
+€5.9m
-0.4%PE15.3x
EAPI Euroapi€3.101.2%
+€3.6m
5.1%PS0.3x
MEDCL MedinCell€26.780.4%
+€3.6m
62.9%PS27.3x
ALTHX THX Pharma Société Anonyme€2.2710.2%
+€2.9m
365.2%PS35.7x
AB AB Science€1.202.0%
+€1.8m
28.1%PS85x

Latest News